Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
31,54 USD | +1,48% | +12,84% | -14,43% |
Attività
Numero di dipendenti: 919
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Next Generation Sequencing Tools
50,5
%
| 99 | 48,8 % | 124 | 50,5 % | +24,56% |
Synthetic Genes
30,0
%
| 62 | 30,2 % | 74 | 30,0 % | +19,56% |
Antibody Discovery
9,5
%
| 24 | 11,9 % | 23 | 9,5 % | -4,13% |
Oligo Pools
5,9
%
| 12 | 6,1 % | 14 | 5,9 % | +16,62% |
DNA Libraries
4,2
%
| 6 | 3,0 % | 10 | 4,2 % | +65,90% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Americas
61,7
%
| 122 | 60,2 % | 151 | 61,7 % | +23,51% |
EMEA
29,1
%
| 62 | 30,5 % | 71 | 29,1 % | +15,00% |
APAC
9,2
%
| 19 | 9,3 % | 22 | 9,2 % | +18,11% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
William Banyai
FOU | Founder | 69 | 04/02/13 |
Emily Leproust
CEO | Chief Executive Officer | 50 | 01/04/13 |
Adam Laponis
DFI | Director of Finance/CFO | 47 | 05/01 |
Patrick Finn
PSD | President | 53 | 03/02/15 |
Chet Gandhi
CTO | Chief Tech/Sci/R&D Officer | - | 20/06/23 |
Chief Tech/Sci/R&D Officer | - | 01/03/14 | |
Siyuan Chen
CTO | Chief Tech/Sci/R&D Officer | - | 01/12/20 |
Aaron Sato
CTO | Chief Tech/Sci/R&D Officer | - | - |
Dennis Cho
CMP | Compliance Officer | 53 | 27/09/21 |
Angela Bitting
IRC | Investor Relations Contact | - | 01/11/20 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Robert Ragusa
BRD | Director/Board Member | 64 | 01/11/16 |
Jan Johannessen
BRD | Director/Board Member | 67 | 01/10/18 |
Keith Crandell
BRD | Director/Board Member | 63 | 01/10/13 |
Robert Chess
BRD | Director/Board Member | 66 | 01/06/14 |
Nelson Chan
BRD | Director/Board Member | 62 | 01/05/19 |
William Banyai
FOU | Founder | 69 | 04/02/13 |
Director/Board Member | 58 | 06/08/21 | |
Emily Leproust
CEO | Chief Executive Officer | 50 | 01/04/13 |
Xiaoying Mai
BRD | Director/Board Member | 36 | 01/07/18 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 57 818 022 | 56 788 488 ( 98,22 %) | 0 | 98,22 % |
Coordinate società
Twist Bioscience Corp.
681 Gateway Boulevard
94080, San Francisco
+800 719 0671
http://www.twistbioscience.comSettore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-14,43% | 1,82 Mrd | |
-4,66% | 86,13 Mrd | |
+1,32% | 39,82 Mrd | |
-19,27% | 30,42 Mrd | |
+57,86% | 25,23 Mrd | |
-16,09% | 15,36 Mrd | |
-9,14% | 11,95 Mrd | |
-17,69% | 11,6 Mrd | |
-43,00% | 11,51 Mrd | |
+5,24% | 8,71 Mrd |
- Borsa valori
- Azioni
- Azione TWST
- Società Twist Bioscience Corporation